We are studying whether oxytocin can safely support educational measures for children aged 6 to 12 with autism and intellectual disabilities. This trial will help us understand its feasibility and safety in managing challenging behaviors.
Health conditions and diseases that the clinical trial is designed to study and treat.
Autism Spectrum Disorder (ASD) is a developmental disorder that affects communication and behavior, while Intellectual Disability refers to limitations in intellectual functioning and adaptive behavior. Together, they can impact learning, social skills, and daily functioning.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.